HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hein, G Articles by Franke, S Search for Related Content PubMed PubMed Citation Articles by Hein, G Articles by Franke, S

Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings

¹ Department of Internal Medicine III, Rheumatology and Osteology, Friedrich-Schiller, University Jena, Germany
² Department of Clinical Preventive Medicine, Nagoya University Hospital, Nagoya, Japan

Correspondence to:
Correspondence to:
Professor G Hein
Section of Rheumatology and Osteology, Department of Internal Medicine III, Erlanger Allee 101, D-07740 Jena, Germany; gert.hein{at}med.uni-jena.de

ABSTRACT
Background: The process of bone remodelling is disturbed in the development of osteoporosis.

Objective: To investigate if proteins in osteoporotic bone are modified by advanced glycation end products (AGEs), and whether these alterations are related to measures of bone remodelling based on histomorphometric findings.

Methods: Bone specimens taken from the iliac crest by bone biopsy of eight osteoporotic patients were investigated by histomorphometry and by immunohistochemical staining with the AGEs imidazolone and N-carboxymethyllysine.

Results: Both AGEs were found in all bone specimens. The intensity of staining correlated with patient age. The percentage of bone surface covered with osteoblasts showed a significantly negative correlation with the staining intensity of both AGEs.

Conclusions: It is known that AGEs can regulate proliferation and differentiation of osteoblastic cells and that AGE-specific binding sites are present in cultured osteoblast-like cells. Moreover, AGE induced biological effects in these cells might be mediated by RAGE (receptor of AGE) or by other AGE receptors in different stages of osteoblast development. The inverse relation between AGE staining intensity and the percentage of bone surface covered with osteoblasts in the trabecular bone may provide evidence that AGE modification of bone proteins disturbs bone remodelling.

Abbreviations: AGE, advanced glycation end product; CML, N-carboxymethyllysine

Keywords: glycation end products; bone remodelling; histomorphometry; immunohistochenical staining; osteoporosis

This article has been cited by other articles:

				R. SANGUINETI, D. STORACE, F. MONACELLI, A. FEDERICI, and P. ODETTI Pentosidine Effects on Human Osteoblasts in Vitro Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 166 - 172. [Abstract] [Full Text] [PDF]

				U. Valcourt, B. Merle, E. Gineyts, S. Viguet-Carrin, P. D. Delmas, and P. Garnero Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation J. Biol. Chem., February 23, 2007; 282(8): 5691 - 5703. [Abstract] [Full Text] [PDF]